Introduction

Pyoderma Gangrenosum (PG) is an ulcerative disorder of the skin.  Although the name sounds like it's an infectious disease, it isn't caused by any infection. This rare condition of skin disease is mainly associated with systemic disease. The final diagnosis is made clinically by excluding other similar skin diseases or disorders. In this article, we are going to discuss the clinical criteria for the diagnosis of  PG as well as the exclusion of other conditions.¹

The systemic disorders that are associated with PG   are rheumatoid arthritis, inflammatory bowel disease, and other autoimmune disorders and inflammatory conditions (the author should mention the conditions here by name). In addition to this, PG  also has an association with both solid (author please explain this)  and haematologic tumours and malignancies.¹

PG is often confused and misinterpreted as a recurrent necrotising soft tissue infection or vasculitis manifestation, which poses challenges in diagnosing PG. This often leads to a delay in appropriate therapeutic interventions.² If there is a persistent tentor? (Please explain this term.) lesion in a patient, and it is either unresponsive to antibiotics or associated with negative cultures. These indications, if paired with other indicative systemic conditions, should prompt consideration of the alternative diagnosis of PG. Proactive diagnosis in this kind of disease plays a crucial and necessary role.²

Clinical criteria for diagnosing PG

 PG is mainly diagnosed by its characteristic appearance and severe pain. A pathergy test usually comes back positive. The area where the wound is formed should be swabbed and cultured for microorganisms as a specimen. If the test comes back negative, further tests need to be done, such as a skin biopsy, which will rule out other causes of ulceration.³

The common interpretation of PG is an extremely painful erythematous lesion that later rapidly converts into a blistered or necrotic ulcer. Although PG can be present at any site of the body, it mainly affects the lower legs. PG   normally affects adults and rarely children. In some patients, there can be a possibility of family history in the generations, but it has been found that the majority of patients do not have any family inheritance.⁴

If there are any systemic underlying diseases, they must be treated, but there is no direct correlation between underlying systemic disease and the severity of  PG 

The use of systemic immunosuppressants can be taken into consideration by how fast the disease progresses. The lesion's size is rapidly growing, so systemic medications like corticosteroids or cyclosporine can be used.¹

Investigations

The investigations are done by testing the blood samples of patients, including various tests like complete blood count (CBC), haemoglobin A1c (HbA1c), and liver function tests (LFTs). If the patient is casual about  PG, then extensive serological evaluation is also advised, which includes Rheumatoid factor, Antinuclear  Antibody, and anti-double-stranded (ds). Based on this, the following tests were advised to investigate further. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), serum electrolytes, renal function tests, serum urea and creatinine tests were advised.⁵

Imaging techniques, such as magnetic resonance imaging (MRI), make the diagnosis even easier and save the patients from further complications. MRI can

determine the degree and extension of cellulitis, such as skin thickening and increased signal intensity within subcutaneous soft tissue in the fluid-sensitive areas.⁶

Diagnostic Scoring Systems

In the past, there were fewer standardised diagnostic and histological criteria available for the diagnosis of PG, which added difficulty in recognising the exact cause of PG lesions.  Over time, three main diagnostic criteria have been developed to make it easier the recognise PG.^7,8

The new diagnostic tools include the  PARACELSUS score, based on the point system, which was proposed in 2018, and the Delphi Consensus criteria, which still needs to fulfil some requirements for its use. There is also one criterion that the author please explain what this means author proposed this in 2004, and it is based on two major and minor criteria; however, its performance has not been assessed in a clinical setting (you didn't explain the name of this tool, author?). All three diagnostic tools have beneficial uses, but they also have limitations in identifying cases of PG. Each of the above-mentioned three diagnostic frameworks emphasises distinct aspects of the disease. Despite their differences, they all performed quite well in identifying cases of PG, with the highest score identifying with PARACELSUS. In Su and PARACELSUS criteria, skin biopsy is considered an additional or minor criterion. On the contrary, in the Delphi criteria, skin biopsy with neutrophilic infiltrate is considered the only criterion required for the diagnosis of PG.^8,9

Summary

PG is a rare and non-infectious ulcerative disorder,  classified under neutrophilic dermatoses. As the name indicates, it is an infectious disease, but in a practical scenario (this needs a better explanation/rewording?), it is not an infectious disease.PG is associated with systemic conditions like rheumatoid arthritis, inflammatory bowel diseases, and certain malignancies.

There are many challenges in diagnosing  PG as it has a resemblance to other infections and ulcerative skin conditions. It is a diagnosis of exclusion, primarily relying on specific clinical criteria, and in many conditions, there is a need to eliminate other similar conditions. Diagnostic tools such as skin biopsy are useful for ruling out other diseases but should be used cautiously due to the risk of pathergy, a condition where minor trauma causes new lesions. Also, imaging techniques like MRI   can be used for identifying deep tissue involvement. Recently developed Systems, like the PARACELSUS score and the Delphi Consensus criteria, are the emerging tools for the diagnosis of PG.

FAQs

Q1: What is pyoderma gangrenosum?

Pyoderma Gangrenosum (PG) is a non-infectious, ulcerative skin disease that causes painful sores and is often associated with systemic diseases like rheumatoid arthritis and inflammatory bowel disease.

Why is PG challenging to diagnose?

A: PG mimics infections and other ulcerative conditions. It has no definitive diagnostic test and is primarily diagnosed by excluding other possibilities and using clinical criteria.

Q3: What are the major and minor criteria for diagnosing PG?

• Major Criteria: Rapidly progressing painful ulcer with undermined borders, and exclusion of other causes.
• Minor Criteria: History of pathergy, associated systemic disease, characteristic histopathological findings, and response to treatment

Q4: What is pathergy, and why is it important in PG?

A: Pathergy is a phenomenon where minor trauma (like a needle prick or biopsy) causes a new lesion or worsens an existing one. It's significant in PG diagnosis and limits the use of skin biopsies.

Q5: Is a skin biopsy always necessary for PG?

A: No, biopsies are used cautiously due to the risk of pathergy and the lack of specific histological findings in PG. They are mainly performed to rule out infections, cancers, or other ulcerative conditions.

Q6: What investigations are done to support PG diagnosis?

A: Blood tests (CBC, ESR, CRP, LFTs, HbA1c), autoimmune markers (ANA, rheumatoid factor), and sometimes MRI imaging to assess tissue involvement.

Q7: Are there any diagnostic scoring systems for PG?

A: Yes, systems like PARACELSUS, Delphi Consensus, and Su criteria help guide the diagnosis. PARACELSUS is considered the most accurate among them.

Q8: How is PG treated?

A: The primary treatment involves systemic immunosuppressants like corticosteroids and cyclosporine. Treating any underlying systemic disease is also crucial.